These new recommendations supplement the guideline recommendations issued in 2013. Anastrozole 1 mg/day is now added to three other endocrine agents (tamoxifen 20 mg, raloxifene 60 mg, and exemestane ...
Tamoxifen treatment has been linked to an excess risk of nonalcoholic steatohepatitis, which is characterized by inflammation and fatty deposits in the liver. Bruno and colleagues have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback